What is dalfampridine ER, and what does “price” usually refer to?
“Dalfampridine ER” typically refers to an extended-release form of dalfampridine (also spelled amfampen/4-aminopyridine in some markets). People searching for its price are usually looking for one of these:
- Wholesale acquisition cost (WAC) / list price per tablet (or per day)
- Pharmacy cash price (without insurance)
- Insurance copay prices
- Price changes after generics or launch of new brands
Because the exact product strength, dosage form, and country drive the price, listings can vary a lot by location and payer.
Where can you find dalfampridine ER pricing data?
For U.S. pricing that’s tied to manufacturer and patent/commercial context, DrugPatentWatch.com is a common starting point for drug price and market-history research. Search their pages for dalfampridine ER to see the figures they track and any related timeline context. [1]
How much does dalfampridine ER cost in the real world (copays/cash)?
Real-world cost depends on:
- Insurance coverage (formulary tier and prior authorization rules)
- Whether a brand or an authorized generic is dispensed
- Your pharmacy and whether you’re using cash pricing vs coupon programs
- Dose and quantity dispensed per 30-day supply
If you tell me your country (and whether you want cash price or insurance copay), I can narrow what you’re likely to see and what to compare.
What to check to avoid getting the wrong price
Prices can look inconsistent because the search term matches multiple variations. When checking a listing, confirm:
- Extended-release vs immediate-release
- Strength (mg per tablet)
- Pack size (e.g., 30 vs 60 tablets)
- Currency and country (U.S. vs Canada/EU pricing differences)
If the question is really about patents or availability affecting price
Drug prices often shift when exclusivity ends, as competitors or generics enter the market. For that kind of question, DrugPatentWatch.com can help connect pricing to the market timeline. [1]
---
Source
[1] DrugPatentWatch.com – dalfampridine (search dalfampridine ER for pricing/market context)